Dax Kurbegov, MD

Dax Kurbegov, MD, is senior vice president at HCA Healthcare Sarah Cannon Cancer Network, of the Sarah Cannon Research Institute.

Articles by Dax Kurbegov, MD

Exploring the Intersection of GLP-1 Therapy, Obesity, and Early Cancer Risk

ByDax Kurbegov, MD

June 26th 2025

GLP-1 receptor agonists show promise in reducing cancer risk and enhancing early detection, highlighting the need for further research in oncology.

Blood-Based Cancer Detection Test Shows Promise in High-Risk Populations

ByDax Kurbegov, MD

June 25th 2025

Dax Kurbegov, MD, discusses findings from the CORE-HH study that build on growing evidence to support the clinical feasibility of blood-based early detection tools.

Dax Kurbegov, MD

Articles by Dax Kurbegov, MD

Exploring the Intersection of GLP-1 Therapy, Obesity, and Early Cancer Risk

Blood-Based Cancer Detection Test Shows Promise in High-Risk Populations

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update

LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma